Skip to content

Clinical trials

Hyperhomocysteinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperhomocysteinemia Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20071
20081
20092
20102
20111
20123
20132
20141
20154
20182
20193
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status5
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
S.LAB (SOLOWAYS)2
Shenzhen Ausa Pharmed Co.,Ltd2
Asociación Científica Latina A.C.1
Assiut University1
Bangkok Metropolitan Administration Medical College and Vajira Hospital1
Baylor Research Institute1
Center for Health Sciences, Serbia1
Clionsky Neuro Systems Inc.1
Dr. Loges & Co. GmbH1
Fuling Central Hospital of Chongqing City1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperhomocysteinemia33
Cardiovascular Diseases7
Hypertension7
Vitamin B 12 Deficiency4
Cognitive Dysfunction3
Dementia3
Heart Diseases3
Coronary Disease2
Kidney Failure, Chronic2
Myocardial Infarction2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.